STOCK TITAN

Insider sales at VIR (NASDAQ: VIR) include multiple February 2026 transactions

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

VIR filed a Rule 144 notice reporting proposed sales of Common Stock and recent dispositions by an insider. The filing lists restricted stock vesting events of 02/13/2026 (2,220 shares), 02/23/2026 (2,546 shares) and 02/24/2026 (2,945 shares).

The excerpt also shows recent sales by Brent Sabatini during the past three months, including 1,530 shares on 02/13/2026 and 1,829 shares on 02/23/2026

Positive

  • None.

Negative

  • None.

Insights

Rule 144 notice documents proposed sales and recent dispositions by an insider.

The filing lists issuer-reported restricted stock vesting of 02/13/2026 (2,220 shares), 02/23/2026 (2,546 shares) and 02/24/2026 (2,945 shares). These vesting events create shares that may be eligible for resale under applicable safe-harbors.

Sales by Brent Sabatini are reported for 02/13/2026 (1,530 shares), 02/23/2026 (1,829 shares) and 02/24/2026 (1,430 shares). Timing, holding period, and manner of sale determine Rule 144 availability; the filing excerpt does not specify sale methods or price aggregation.

Vesting and subsequent Form 144 activity signal routine insider liquidity events, per the excerpt.

Restricted stock vesting on three dates in February 2026 creates potential supply; the excerpt quantifies those shares as 2,220, 2,546, and 2,945.

The selling activity by Brent Sabatini across the same period is shown with per-transaction share counts and proceeds figures. The excerpt does not state whether proceeds accrue to the issuer or selling holder.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does VIR's Form 144 filing show?

It reports proposed sales of Common Stock and recent insider dispositions. The excerpt lists restricted stock vesting on 02/13/2026 (2,220 shares) and sales by Brent Sabatini in February 2026.

How many shares vested for VIR in February 2026?

The filing lists three vesting events totaling specific tranches. It shows 2,220, 2,546, and 2,945 shares vesting on 02/13/2026, 02/23/2026, and 02/24/2026, respectively.

Which insider sold shares recently according to the VIR excerpt?

Brent Sabatini is shown as the selling party with multiple transactions. The excerpt records sales of 1,530, 1,829, and 1,430 shares on February dates in 2026.

Do the reported sales in VIR's Form 144 indicate how proceeds are used?

No, the excerpt does not state proceeds allocation. The tables show per-transaction proceeds figures but do not specify whether proceeds go to the issuer or selling holder.

Are the vesting shares immediately eligible for resale under Rule 144?

Eligibility depends on holding periods and conditions under Rule 144. The excerpt lists vesting dates and share counts but does not state holding-period or method-of-sale details.
Vir Biotechnology, Inc.

NASDAQ:VIR

View VIR Stock Overview

VIR Rankings

VIR Latest News

VIR Latest SEC Filings

VIR Stock Data

1.45B
126.51M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
SAN FRANCISCO